Fact-checked by Grok 2 weeks ago

Scabies

Scabies is a contagious ectoparasitic skin infestation caused by the microscopic mite Sarcoptes scabiei var. hominis, which burrows into the upper layer of the skin to lay eggs, triggering an allergic reaction that leads to intense itching and a pimple-like rash.^[1]^[2]^[3] The female mite tunnels through the stratum corneum, depositing 2–3 eggs per day over her 4–5 week lifespan, while the resulting hypersensitivity to mite antigens, feces, and saliva causes the hallmark pruritus, which is often most severe at night.^[4] Common manifestations include linear burrows, erythematous papules, and vesicles, typically appearing in skin folds such as between the fingers, on the wrists, elbows, axillae, and genitals, though infants and young children may exhibit widespread involvement including the face, scalp, palms, and soles.^[2]^[3] In immunocompromised individuals, a severe variant known as crusted (or Norwegian) scabies can develop, characterized by hyperkeratotic crusts containing thousands to millions of mites and posing a heightened transmission risk.^[1]^[4] Transmission of scabies occurs primarily through prolonged direct skin-to-skin contact, requiring as little as 10–20 minutes for classic cases, though crusted scabies can spread more readily via brief contact or fomites such as infested bedding, clothing, or towels.^[2]^[3] Symptoms often do not appear until 2–6 weeks after initial infestation in previously unexposed individuals, allowing asymptomatic carriers to unknowingly propagate outbreaks, particularly in crowded or close-contact settings like households, nursing homes, prisons, and child care facilities.^[1]^[4] Globally, scabies affects more than 200 million people at any time and more than 400 million people cumulatively every year, with higher prevalence in tropical regions, resource-poor communities, and among children aged 5–14 years, where rates can reach 5–50% in endemic areas of Africa, Latin America, and Southeast Asia.^[1]^[2] The condition is classified as a neglected tropical disease by the World Health Organization, contributing to significant morbidity through secondary bacterial infections like impetigo and post-streptococcal glomerulonephritis.^[1]^[4] Diagnosis of scabies relies on clinical presentation, supported by microscopic identification of mites, eggs, or fecal scybala from skin scrapings, though dermoscopy or adhesive tape tests may aid visualization of burrows in ambiguous cases.^[3]^[4] Treatment involves scabicidal agents, with first-line options including topical 5% permethrin cream applied from the neck down and left on for 8–14 hours, or oral ivermectin (200 μg/kg, repeated after 1–2 weeks) for classic scabies, while crusted cases may require multiple doses combined with keratolytics and longer regimens.^[2]^[1] All household and close contacts should be treated simultaneously, even if asymptomatic, to prevent reinfestation, and itching may persist for 2–4 weeks post-treatment due to ongoing hypersensitivity.^[3]^[4] Complications such as bacterial superinfections necessitate antibiotics like topical mupirocin or oral cephalexin.^[1] Prevention strategies emphasize avoiding direct skin contact with infested individuals and decontaminating potentially fomites by machine-washing in hot water (at least 50°C/122°F) followed by high-heat drying, or sealing non-washable items in plastic bags for at least 72 hours, as mites cannot survive off the human host beyond 2–3 days.^[2]^[3] Environmental cleaning, including vacuuming of furniture and carpets, further reduces risk in institutional outbreaks, though animal-derived scabies mites (e.g., from dogs or cats) cause temporary, self-limited dermatitis in humans without reproduction.^[1]^[4] Mass drug administration with ivermectin has shown efficacy in controlling community outbreaks in high-prevalence settings.^[1]

Clinical Presentation

Typical Signs and Symptoms

Scabies infestation in immunocompetent individuals typically manifests with intense pruritus, which is often more severe at night due to increased mite activity.^[5] This itching arises from a delayed hypersensitivity reaction to the mites, their eggs, and feces, with symptoms generally beginning 4 to 6 weeks after initial infestation in those not previously exposed, though it can onset within 1 to 4 days in sensitized individuals.^[1]^[6] The incubation period allows for mite reproduction and sensitization before the allergic response triggers noticeable discomfort.^[3] The characteristic rash consists of erythematous papules, vesicles, and excoriations from scratching, distributed symmetrically in specific body areas.^[4] In adults, lesions commonly appear in the interdigital spaces of the hands, wrists, elbows, axillae, waistline, and genital region.^[7] In children, the rash may also involve the face, scalp, palms, and soles, reflecting differences in skin folding and mite preference.^[8] Linear burrows, representing the mites' tunnels, are a hallmark feature, appearing as thin, wavy, grayish-white lines measuring 1 to 10 mm in length on the skin surface.^[9] Scratching due to pruritus frequently leads to secondary bacterial infections, such as impetigo or cellulitis, particularly from Streptococcus pyogenes and Staphylococcus aureus.^[7] These complications arise from breaches in the skin barrier, increasing the risk of localized or systemic spread if untreated.^[10] In typical cases, symptoms progress from initial burrowing to widespread rash and itching without the hyperkeratotic plaques seen in crusted variants.^[2]

Crusted Scabies

Crusted scabies, also known as Norwegian scabies, represents a severe, hyperinfestive form of scabies infestation caused by an extraordinarily high burden of Sarcoptes scabiei mites, often numbering in the thousands to millions within the skin.^[11] This leads to widespread, thick, crusted, and hyperkeratotic lesions that can cover extensive areas of the body, including the scalp, face, neck, trunk, extremities, and nails, where subungual hyperkeratosis and onycholysis may occur.^[4] Unlike typical scabies, which features limited mite numbers and intense pruritus, crusted scabies often presents with minimal or absent initial itching due to the host's impaired immune response, allowing unchecked mite proliferation.^[11] As the condition progresses, symptoms may evolve to include severe complications such as bacterial superinfections from pathogens like Staphylococcus aureus or Streptococcus pyogenes, potentially leading to sepsis, cellulitis, or even mortality if untreated. This variant predominantly affects immunocompromised individuals, including those with HIV/AIDS, organ transplant recipients on immunosuppressive therapy, elderly patients with dementia or frailty, and individuals with conditions limiting mobility or self-care, such as paralysis or severe cognitive impairment.^[4] The hyperkeratotic crusts result from excessive keratin production in response to the massive mite load, creating a scaly, fissured surface that flakes off easily.^[12] Crusted scabies is highly contagious, far exceeding the transmission risk of typical scabies, due to the shedding of vast numbers of mites and eggs in skin debris, scales, and crusts, which can contaminate environments and fomites like bedding or clothing.^[13] This poses significant outbreak risks in institutional settings, such as nursing homes, long-term care facilities, and hospitals, where close contact and shared items facilitate rapid spread among residents and staff.^[14] Diagnosis of crusted scabies is challenging because its atypical presentation—lacking the classic burrows, papules, and intense itch of standard scabies—often leads to initial misdiagnosis as conditions like psoriasis, eczema, seborrheic dermatitis, or contact dermatitis.^[12] The extensive scaling and erythroderma can mimic these dermatoses, delaying recognition until microscopic examination of skin scrapings reveals the profuse mites, eggs, and fecal matter confirmatory of the infestation.^[4]

Etiology and Pathogenesis

Causative Agent

Scabies is caused by the mite Sarcoptes scabiei var. hominis, an obligate ectoparasite belonging to the arthropod class Arachnida, subclass Acari, and family Sarcoptidae.^[6] This microscopic arachnid measures 0.2–0.4 mm in length, with adults possessing four pairs of short, stubby legs equipped with claws and empodia for burrowing.^[6]^[15] Females are larger, typically 0.30–0.45 mm long and 0.25–0.35 mm wide, while males are smaller at 0.20–0.24 mm long and 0.15–0.20 mm wide; the mite's body is oval, dorsally convex, and ventrally flat, covered in fine spines.^[6]^[15] The lifecycle of S. scabiei var. hominis occurs entirely on the host's skin and consists of four stages: egg, larva, nymph, and adult, completing in 10–17 days under optimal conditions.^[6]^[16] Upon mating, the gravid female burrows tortuous tunnels into the stratum corneum of the epidermis, where she deposits 2–3 eggs per day for up to 4–5 weeks, producing a total of 40–50 eggs during her 1–2 month lifespan.^[6]^[15] Eggs are oval, measuring 0.10–0.15 mm, and hatch in 3–4 days into hexapod larvae with three pairs of legs, which then migrate to the skin surface to form molting pouches.^[6] Larvae develop through two nymphal stages—protonymph and tritonymph, each with four pairs of legs—over 3–4 days before emerging as adults to continue the cycle.^[6]^[16] The variant S. scabiei var. hominis is specifically adapted to humans, thriving at skin surface temperatures of 32–35°C and neutral pH levels characteristic of human epidermis. This adaptation enables efficient burrowing and reproduction in the warm, moist environment of human skin, with optimal activity between 30–37°C. Off the host, S. scabiei var. hominis survives only briefly, up to 2–3 days in cool (10–21°C), humid conditions with relative humidity above 75–97%, but viability drops sharply in dry or hot environments, with death occurring within 24–48 hours at room temperature (21°C) and 40–80% humidity.^[15]^[17] The mite elicits an allergic response through antigens in its fecal pellets, known as scybala, and saliva; these contain proteins such as serpins and glutathione S-transferases that trigger type I (immediate) and type IV (delayed) hypersensitivity reactions in the host.^[18]^[19]

Transmission Mechanisms

Scabies is primarily transmitted through prolonged direct skin-to-skin contact with an infested individual, typically requiring at least 10 to 20 minutes of close interaction, such as occurs between sexual partners, household members, or caregivers.^[9]^[4] This mode is most efficient in intimate or crowded settings, including households, prisons, and nursing homes, where sustained physical proximity facilitates mite transfer from burrows in the host's skin.^[20]^[21] Indirect transmission via fomites, such as infested bedding, clothing, or towels, is possible but less common in typical cases due to the mite's limited survival off the host, which ranges from 24 to 72 hours under optimal room temperature and humidity conditions.^[9]^[21] In contrast, crusted scabies—a severe form with millions of mites—is highly contagious through fomites, as the heavy mite burden allows rapid spread even with brief contact or shared items.^[4]^[20] Individuals become contagious shortly after mite infestation, often asymptomatically during the early phase before symptoms appear (incubation period of 2 to 6 weeks for first-time infestations), and remain so from the start of egg-laying until approximately 24 to 48 hours after effective treatment eradicates the mites and eggs.^[9]^[21] Transmission risk is amplified by factors such as overcrowding, poor personal hygiene, and institutional living environments like barracks or homeless shelters, which promote frequent close contacts.^[20]^[4] Scabies is not spread by casual contact, such as handshakes or hugs, nor by insects acting as vectors; animal-to-human transmission occurs only rarely in zoonotic cases involving mites adapted to non-human hosts.^[20]^[9] Global outbreaks are often linked to social determinants like poverty, which exacerbate overcrowding and limited access to hygiene resources.^[4]^[21]

Pathophysiological Processes

The female Sarcoptes scabiei mite initiates infestation by burrowing into the stratum corneum of the human epidermis, excavating tunnels approximately 1-10 mm in length using its mouthparts and forelegs while secreting saliva containing proteolytic enzymes to dissolve the surrounding keratin and tissue.^[4] This process, which takes about 20 minutes for adult females, allows the mite to feed on liquefied epidermal cells, intercellular fluids, and lymph, while laying 2-3 eggs per day and depositing fecal pellets (scybala) within the burrow.^[22] Over the course of 2-4 weeks, the eggs hatch into larvae that continue the colonization, with mite densities typically reaching 10-15 adults in ordinary scabies, though burrows remain confined to the uppermost skin layers without penetrating deeper dermis.^[4] Initial infestation often remains asymptomatic for 2-6 weeks as the host develops immune sensitization to mite antigens, including salivary proteins, fecal extracts, and excretory-secretory products released during burrowing.^[23] Upon re-exposure or during persistent infestation, this sensitization triggers an IgE-mediated type I hypersensitivity reaction, where mite-specific IgE binds to mast cells and basophils, leading to degranulation and histamine release. Concurrently, a type IV delayed hypersensitivity response develops, dominated by Th1, Th2, and Th17 CD4+ T-cell activation against mite antigens, resulting in cytokine production (e.g., IL-4, IL-5, IL-13, IL-17, IL-31) that recruits eosinophils and promotes epidermal inflammation; IL-31, produced by Th2 cells and macrophages, is a primary mediator of the intense, nocturnal pruritus.^[22]^[24]^[25] Transcriptomic studies have identified upregulation of chemokines such as CXCL8 and CCL17 in lesional skin, contributing to the inflammatory milieu.^[25] The inflammatory cascade culminates in the formation of papules, vesicles, and burrows as eosinophils and macrophages infiltrate the epidermis, responding to accumulated scybala and mite debris that provoke a localized granulomatous reaction.^[4] This type IV response, peaking 4-6 weeks post-infestation, upregulates pro-inflammatory cytokines such as TNF-α and IL-8, exacerbating skin barrier disruption and edema, while mite-derived immunomodulators (e.g., complement inhibitors in feces) further dampen innate defenses, including suppression of antimicrobial peptides, to favor parasite survival and secondary bacterial infections.^[22]^[26] Vigorous scratching due to pruritus causes excoriations that breach the compromised skin barrier, facilitating secondary bacterial invasion, particularly by Staphylococcus aureus and Streptococcus pyogenes, leading to impetigo, cellulitis, or abscesses.^[23] In severe cases, S. pyogenes superinfection can trigger post-streptococcal glomerulonephritis through immune complex deposition or rheumatic fever via molecular mimicry.^[4] Mite secretions that inhibit host complement activation enhance bacterial adherence and proliferation within lesions, amplifying infection risk.^[22] In crusted (Norwegian) scabies, host factors such as impaired T-cell immunity—often in immunocompromised individuals (e.g., those with HIV, organ transplants, or elderly frailty)—permit unchecked mite proliferation, with burdens exceeding millions and minimal inflammatory response due to reduced Th1 cytokine production and IL-10 dysregulation.^[23] This leads to hyperkeratotic crusts laden with mites and eggs, as defective cell-mediated immunity fails to mount the typical eosinophilic and granulomatous reactions seen in ordinary scabies.^[4]

Diagnosis

Clinical Assessment

The clinical assessment of scabies begins with a detailed history taking to identify key features suggestive of infestation. Patients typically report intense pruritus that worsens nocturnally, often starting 2 to 6 weeks after initial exposure, though sensitized individuals may experience symptoms within 1 to 4 days of reinfestation.^[4]^[27] Inquiring about close skin-to-skin contact with infested individuals, such as household members or sexual partners, is essential, as scabies spreads primarily through prolonged direct contact.^[28] A history of similar symptoms in close contacts or household outbreaks further supports suspicion, particularly in settings like long-term care facilities.^[27] Physical examination focuses on identifying characteristic lesions and their distribution, performed under adequate lighting with a full-body inspection. Primary lesions include erythematous papules, vesicles, or excoriations, commonly distributed in interdigital webs, flexor surfaces of wrists, elbows, axillae, umbilicus, waistline, buttocks, and genitalia, with genital involvement more frequent in males.^[4] Burrows, the hallmark sign, appear as linear or serpiginous tracks, 1 to 10 mm long, often whitish or skin-colored, ending in a minute vesicle or papule containing the mite; they are most visible in non-keratinized areas like finger webs and wrists.^[27]^[28] To enhance detection, the burrow ink test involves applying fountain pen ink to a suspicious site, gently rubbing it in, and wiping off excess with an alcohol swab, revealing the burrow as a persistent dark, wavy line.^[27] Magnification aids in burrow confirmation during examination. Under dermoscopy at 10x magnification, burrows may show as a linear tract with scybala (fecal pellets) resembling a "jet with contrail" or "jetliner trail," while the mite itself appears as a "delta sign"—a triangular, brown-black structure at the burrow's end.^[4]^[28] These in vivo visualizations of mites, eggs, or feces improve diagnostic accuracy, with dermoscopy demonstrating high sensitivity and specificity when performed by trained clinicians.^[27] In at-risk populations, such as the immunocompromised (e.g., those with HIV, diabetes, or elderly individuals), red flags for crusted scabies include widespread hyperkeratotic, scaling lesions on the scalp, hands, feet, or trunk, often with reduced pruritus despite a high mite burden of thousands to millions.^[4]^[28] If clinical findings are atypical, brief consideration of differential diagnoses or confirmatory tests may be warranted to exclude mimics.^[27]

Differential Diagnosis

Scabies can be challenging to diagnose clinically due to its similarity to other pruritic skin conditions, necessitating consideration of the patient's history, lesion distribution, and specific features to rule out mimics. Accurate differentiation is crucial, as misdiagnosis may lead to inappropriate treatments and delayed management of the infestation.^[4] Among pruritic dermatoses, atopic dermatitis often presents with flexural involvement, a personal or family history of atopy, and generalized dry, eczematous patches without the pathognomonic burrows seen in scabies. Contact dermatitis, in contrast, is typically localized to areas of allergen or irritant exposure, with a clear history of such contact and no burrows or mite evidence.^[29]^[30] Other infestations that mimic scabies include pediculosis, characterized by visible lice nits or adults on hair shafts but lacking burrows, and flea bites, which produce punctate, transient pruritic papules often in clusters without linear tracks. The crusted (Norwegian) variant of scabies must be distinguished from hyperkeratotic conditions like severe psoriasis, though the former features thick crusts with numerous mites rather than well-demarcated plaques.^[4]^[30] Additional differentials encompass eczema, which shares itchy, inflamed skin but lacks nocturnal intensification of pruritus and burrows; psoriasis, marked by silvery-scaled plaques on extensor surfaces with less intense itching; urticaria, presenting with evanescent wheals that resolve within hours; and drug eruptions, often accompanied by systemic symptoms like fever or eosinophilia.^[29]^[3]^[4] Key differentiators for scabies include the presence of linear burrows, particularly in interdigital spaces, wrists, and genitals, along with a history of close contact with infested individuals, which are absent in most mimics. In cases of ambiguity, biopsy or microscopic examination can confirm the diagnosis by identifying mites, eggs, or scybala. In children and the elderly, overlapping conditions such as diaper rash or seborrheic dermatitis may occur, but scabies is guided by its characteristic distribution (e.g., avoiding the face in adults) and epidemiological context like institutional outbreaks.^[30]^[29]^[4]

Confirmatory Tests

When clinical diagnosis of scabies is uncertain, confirmatory tests provide objective evidence by detecting the mite Sarcoptes scabiei, its eggs, or fecal remnants.^[6] These methods are employed selectively, as clinical suspicion often suffices, but they are essential in atypical presentations or low-burden infestations.^[31] Skin scraping is the traditional and most accessible laboratory method for confirmation. The procedure entails applying mineral oil to a burrow or unexcoriated papule, then using a sterile scalpel or needle to gently scrape the skin surface and collect scales from the stratum corneum. The material is transferred to a glass slide with a drop of mineral oil, covered with a coverslip, and examined under light microscopy at 10x-40x for screening and 200x-400x for confirmation; for crusted scabies, 10% KOH may be added to dissolve excess keratin prior to examination. Adult female mites (0.30-0.45 mm long by 0.25-0.35 mm wide), ovoid eggs (0.10-0.15 mm), larvae, or scybala (fecal pellets) are identifiable. This test offers high specificity (near 100%) but moderate sensitivity (approximately 56%), with yield improved in crusted scabies due to higher mite density in hyperkeratotic lesions.^[6]^[31]^[32]^[27] Adhesive tape test provides a simpler, less invasive option suitable for children or fragile skin. Clear cellophane tape is pressed firmly onto a suspected lesion, such as a burrow or papule, and quickly peeled off to capture superficial debris, which is then adhered sticky-side down to a glass slide for microscopic examination. Staining with ink or methylene blue may enhance visibility of mite structures. This method detects mites, eggs, or scybala with a sensitivity of about 68% and specificity of 100%.^[32]^[27]^[33] Dermoscopy and videodermatoscopy enable rapid, non-invasive visualization using a handheld device with 10x-20x magnification, often aided by immersion fluid like alcohol. Characteristic findings include the "delta sign" or "jet with contrail," where the mite appears as a brown triangular structure at the burrow's end, eggs as blue ovals along linear tracks (S-shaped or wavy burrows 1-10 mm long), and scybala as delta-wing patterns. Videodermatoscopy offers enhanced resolution for deeper burrows or mite extraction. These techniques achieve a sensitivity of 90-91% and are valuable when microscopy is unavailable, though specificity is lower (around 86%).^[34]^[32]^[27]^[35] Molecular tests, primarily real-time PCR, target S. scabiei DNA from skin scrapings, swabs, or biopsies using specific primers for genes like cytochrome c oxidase subunit 1 (cox1). After DNA extraction, amplification detects mite presence even in low-burden or post-treatment cases where mites are scarce. Sensitivity reaches 81-100% depending on the assay, with specificity of 92%, making it useful for research or outbreaks but limited by cost, need for specialized equipment, and non-routine status in clinical practice.^[31]^[32]^[27] Skin biopsy is infrequently performed due to its invasiveness but serves as a definitive option in ambiguous cases. A 3-4 mm punch or shave biopsy from an active lesion is fixed in formalin, embedded in paraffin, sectioned at 3-5 µm thickness, and stained with hematoxylin and eosin (H&E). Histopathology reveals intracorneal mites, eggs, or scybala within the stratum corneum, often with secondary epidermal changes like acanthosis (thickening) and spongiosis (intercellular edema). Polarized light may highlight mite spines. This approach confirms diagnosis but is reserved for when other tests fail.^[6]^[31]

Prevention

Individual Preventive Measures

Individuals can prevent scabies infestation by minimizing direct skin-to-skin contact with infested persons, as the Sarcoptes scabiei mite is primarily transmitted through prolonged physical contact.^[36] Avoiding sharing personal items such as clothing, towels, or bedding that have been in contact with an infested individual further reduces transmission risk.^[1] Maintaining good personal hygiene practices, including frequent handwashing with soap and water, daily bathing, and regular changing of clothes, supports overall prevention efforts, though these measures alone do not eliminate the mite.^[37] In high-risk settings such as healthcare facilities or crowded living environments, wearing gloves or long-sleeved clothing acts as a barrier to minimize skin exposure during close interactions.^[38] Post-exposure prophylaxis is recommended for close contacts of confirmed cases, including household members, even if asymptomatic, to prevent secondary infestations; this typically involves a single application of 5% permethrin cream or two oral doses of ivermectin (200 µg/kg each, administered 7–14 days apart), administered simultaneously with treatment of the index case.^[2]^[39] Environmental decontamination is essential to eliminate mites from personal surroundings: machine-wash clothes, linens, and bedding used in the three days prior to treatment in hot water exceeding 50°C (122°F) for at least 10 minutes, followed by drying on a hot cycle, or opt for dry cleaning.^[36] For non-washable items, seal them in a closed plastic bag for 3 to 7 days, as scabies mites cannot survive more than 2 to 3 days without human skin contact.^[1] Vacuuming carpets, furniture, and mattresses, followed by disposing of the vacuum bag, helps remove any potential mites or eggs.^[1] Education on early symptom recognition empowers individuals to act promptly: intense itching, especially at night, along with linear burrows or papules on areas like the wrists, fingers, or genital region, should prompt isolation from close contacts and immediate medical consultation to initiate treatment and prevent spread.^[2]^[1]

Community and Institutional Strategies

In endemic areas with scabies prevalence exceeding 10%, mass drug administration (MDA) programs involve screening high-risk populations, such as those in remote communities or institutional settings, followed by prophylactic treatment with oral ivermectin at a dose of 200 μg/kg, typically administered in two doses 7–14 days apart to ensure efficacy.^[1]^[40] Ongoing large-scale MDA programs are implemented in countries including Papua New Guinea, Vanuatu, Fiji, and Solomon Islands.^[1] Such interventions have demonstrated substantial reductions in prevalence, with one community trial in the Solomon Islands reporting an 88% decrease from 18.7% to 2.3% within 12 months, highlighting the value of targeting entire populations to interrupt transmission.^[40] In institutional outbreaks, like those in schools or prisons, similar screening of new entrants and exposed individuals is recommended, coupled with treatment to prevent resurgence.^[38] Isolation protocols in institutions emphasize contact precautions to limit spread, including the use of gloves and gowns during care for suspected or confirmed cases, while avoiding direct skin-to-skin contact.^[38] Infested individuals should be quarantined in a single room until at least 24 hours after the first treatment dose, after which they may return to general areas if precautions continue; for crusted scabies, isolation persists until treatment completion.^[41] Cohort nursing, where infested residents are grouped together under enhanced monitoring, is applied in facilities like nursing homes to contain outbreaks without full facility lockdown.^[38] Surveillance efforts in communities and institutions focus on active monitoring of infestation rates, with routine screening of at-risk groups and mandatory reporting of outbreaks to public health authorities to enable rapid response.^[38] The World Health Organization (WHO) endorses such systems as part of neglected tropical diseases (NTD) control, recommending simplified prevalence mapping tools for early detection in high-burden settings like refugee camps or hospitals.^[26] Institutional protocols include maintaining records of cases and notifying other facilities of transfers involving infested individuals to prevent cross-institution transmission.^[41] Education campaigns play a crucial role in community prevention by raising awareness of scabies transmission through prolonged skin contact, thereby reducing stigma and promoting early reporting and treatment adherence.^[1] These initiatives, often delivered via community health workers, emphasize hygiene practices like hot-water washing of bedding and encourage household-wide treatment to break transmission chains, with proven benefits in increasing MDA participation in low-resource areas.^[26] In institutions, staff training on recognition and precautions fosters a vigilant environment, minimizing undetected spread.^[38] Integration of scabies control into broader NTD programs allows for coordinated MDA with interventions against other parasitic diseases, such as lymphatic filariasis, optimizing resources in low-income settings as outlined in the WHO NTD Roadmap 2021–2030.^[42] This approach targets universal health coverage by 2030, with milestones including MDA implementation in 25 endemic countries by 2030 and enhanced surveillance to track progress toward reducing scabies as a public health problem.^[42] Ongoing research supports co-administration of ivermectin with antibiotics like azithromycin to address secondary bacterial infections, further streamlining integrated efforts.^[40]

Treatment

Topical Therapies

Topical therapies serve as the cornerstone of scabies treatment, utilizing scabicidal creams or lotions applied directly to the skin to eliminate Sarcoptes scabiei mites and their eggs.^[43] These agents are preferred for their targeted action and safety profile in standard cases, with permethrin emerging as the first-line option due to its high efficacy and broad applicability, though emerging resistance may reduce effectiveness in some settings.^[43]^[28]^[44] Permethrin 5% cream is the recommended first-line topical treatment for scabies, effective against both mites and eggs with cure rates exceeding 90% after a single application and up to 98% with the standard regimen in low-resistance areas.^[45] However, recent studies as of 2025 indicate increasing resistance, with failure rates of 10-20% or higher in endemic regions, potentially lowering cure rates.^[46]^[47] It is applied to clean, dry skin from the neck down, covering all areas including skin folds, genitals, and the soles of the feet, and left on for 8-14 hours before washing off.^[43]^[48] A repeat application is typically performed after 1-2 weeks to address any newly hatched mites.^[43]^[28] This treatment is safe for individuals aged 2 months and older, including pregnant and breastfeeding people, though consultation with a healthcare provider is advised for infants.^[43]^[48] Proper application guidelines are essential for success, requiring thorough coverage of the entire body surface to ensure contact with all mites, which may be concentrated in interdigital spaces, wrists, and elbows.^[48]^[49] If the patient bathes or showers before the recommended 8-hour minimum contact time, the application must be repeated.^[48] All household members and close contacts should be treated simultaneously, regardless of symptoms, to prevent reinfestation.^[50]^[48] When permethrin is unavailable, contraindicated, or ineffective due to resistance, alternative topical agents include benzyl benzoate 25% lotion, which is applied to the entire body for 24 hours, repeated on day 2 and day 7, though it can cause skin irritation and is generally avoided in children under 2 years and during pregnancy.^[28]^[49] Crotamiton 10% cream or lotion offers a milder option that may soothe post-treatment itching but is less effective than permethrin, with frequent treatment failures reported, and is not recommended for children.^[43]^[28] For infants under 2 months or pregnant individuals, sulfur ointment at 5-10% concentration is a safe alternative, applied nightly for three consecutive nights and repeated weekly as needed, despite its unpleasant odor and messy application limiting patient adherence.^[43]^[48]^[28] Spinosad 0.9% suspension, FDA-approved in 2021 for patients aged 4 years and older, is another alternative for classic scabies, applied topically and left on for 10 minutes before rinsing, with limited long-term data but good tolerability.^[43] Adherence challenges, such as incomplete application or failure to treat contacts, often lead to treatment persistence and reinfestation.^[50] Additionally, post-treatment itching, known as post-scabies syndrome, can persist for 2-4 weeks due to hypersensitivity to dead mites and feces, requiring symptomatic management with antihistamines or topical corticosteroids rather than additional scabicide.^[50]^[48] In cases of treatment failure, systemic options like oral ivermectin may be considered for non-responders.^[48]

Systemic Treatments

Systemic treatments for scabies primarily involve oral ivermectin, an antiparasitic agent effective against the Sarcoptes scabiei mite, recommended as a first-line alternative to topical therapies by health authorities such as the CDC and WHO.^[39]^[1] Ivermectin works by paralyzing and killing the mites, achieving cure rates of approximately 90-95% with appropriate dosing, though it penetrates the skin less effectively than some topicals.^[51] It is particularly indicated for patients with widespread infestations, those who are non-adherent to topical applications, or in institutional outbreaks where ease of administration is crucial.^[52]^[38] The standard regimen consists of a single oral dose of 200 mcg/kg body weight, repeated after 1-2 weeks to target newly hatched mites, with doses taken on an empty stomach for optimal absorption.^[43]^[49] For example, a 60 kg adult would receive 12 mg, typically as four 3 mg tablets.^[53] Ivermectin is recommended only for individuals weighing more than 15 kg due to limited safety data in younger children, and it is contraindicated in pregnancy (FDA pregnancy category C), breastfeeding, or regions endemic for Loa loa infection, where it risks serious encephalopathy from rapid parasite death.^[43]^[54]^[55] Monitoring post-treatment involves assessing for symptom resolution within 2-4 weeks, with follow-up skin scrapings if needed to confirm mite eradication.^[49] Advantages of ivermectin include its systemic action, which simplifies treatment for extensive or crusted scabies, and its utility in mass drug administration campaigns for community control, as endorsed by the WHO.^[1] Common side effects are mild, such as gastrointestinal upset or transient itching due to a Mazzotti-like reaction from dying mites, while rare severe effects like neurotoxicity may occur in high-risk populations.^[56]^[57] In crusted or treatment-resistant cases, combination therapy with oral ivermectin and a topical scabicide like 5% permethrin is recommended to enhance efficacy and reduce recurrence, according to recent clinical guidelines.^[58]^[49] Emerging reports also note potential resistance to ivermectin in some areas.^[26]

Management in Special Cases

Crusted scabies, also known as Norwegian scabies, requires intensified management due to the hyperinfestation with thousands of mites and extensive scaling, often in immunocompromised individuals. Treatment typically involves a combination of oral ivermectin at 200 μg/kg on days 1 and 2, followed by days 8 and 9, or up to three to seven weekly doses in severe cases, alongside repeated applications of topical 5% permethrin every 1-2 weeks. Keratolytic agents such as 5-10% salicylic acid in petrolatum or 40% urea cream are essential to soften and remove thick crusts, facilitating mite penetration by scabicides, and should be applied daily under occlusion until crusts resolve. Patients often require hospitalization for isolation to prevent transmission, along with meticulous wound care to address secondary bacterial superinfections like impetigo or cellulitis, which may necessitate systemic antibiotics like topical mupirocin or oral cephalexin. In pregnant or breastfeeding women, 5% permethrin cream remains the preferred first-line treatment, classified as FDA pregnancy category B with demonstrated safety in multiple studies showing no increased risk of adverse fetal outcomes. Oral ivermectin should be avoided due to limited safety data in pregnancy and potential transfer to breast milk. As an alternative, 6-10% sulfur ointment applied daily for three days, repeated after one week, is considered safe and effective for this population, though it may cause more skin irritation. For infants and young children, 5% permethrin cream is approved from two months of age and applied to the entire body, including the scalp, face (avoiding eyes and mouth), and skin folds, with a repeat application after 7-14 days to account for higher mite burdens and burrows in these areas. Benzyl benzoate 25% lotion serves as a second-line option but must be diluted to 12.5% for children under 5 years or infants to minimize irritation, applied twice daily for three days and repeated after one week, also covering the scalp in young patients where infestations are more common. Spinosad may be considered for children ≥4 years if permethrin fails.^[43] Permethrin resistance has been documented in scabies cases, particularly in regions like Australia with high treatment prevalence, where 2024 reports indicate failure rates exceeding 20% in some communities due to genetic mutations in mite voltage-gated sodium channels; as of 2025, resistance is escalating globally with average failure rates around 10% but higher in endemic areas.^[59]^[44] In such resistant infections, clinicians should switch to oral ivermectin (200 μg/kg, two doses one week apart) as the primary alternative, with emerging trials of moxidectin (a longer-acting avermectin) showing promise in single-dose regimens for refractory cases, though not yet standard or approved for scabies as of 2025.^[60] Follow-up evaluation is crucial 2-4 weeks after treatment initiation to assess for persistent burrows or live mites via skin scraping or dermoscopy, with retreatment recommended if infestation persists. Post-scabetic itch, affecting up to 50% of patients for 2-6 weeks due to hypersensitivity to dead mites and feces, can be managed symptomatically with oral antihistamines like hydroxyzine or diphenhydramine for nocturnal relief, and topical corticosteroids such as hydrocortisone 1% to reduce inflammation, alongside emollients to soothe xerosis.

Outbreak Control

Effective outbreak control for scabies requires rapid case identification through symptom-based screening and contact tracing in affected households, institutions, or communities. Health authorities recommend conducting surveys for pruritic rashes and burrows, particularly in high-risk settings like nursing homes or refugee camps, to detect cases early and map transmission networks.^[38]^[61] This approach facilitates targeted interventions and prevents widespread dissemination, as outbreaks can persist for months without prompt action.^[1] Mass drug administration (MDA) serves as a cornerstone for containing endemic outbreaks, involving treatment of entire populations in areas with scabies prevalence exceeding 10%. The World Health Organization endorses MDA using two doses of oral ivermectin (200 µg/kg body weight, administered 7–14 days apart) for all residents and close contacts, achieving prevalence reductions of up to 79% in systematic reviews.^[1]^[62] Alternatively, topical 5% permethrin can be used where ivermectin is contraindicated, with coverage targets of at least 80% to interrupt transmission.^[62] Such programs have been implemented successfully in Pacific Island nations, demonstrating substantial declines in both scabies and secondary bacterial infections.^[62] Environmental measures complement pharmacological interventions by reducing mite survival outside the host. Communal areas should be vacuumed and disinfected, while shared bedding, clothing, and linens are machine-washed in hot water (at least 50°C) and dried on high heat, or sealed in plastic bags for 72 hours to 7 days if laundering is unavailable.^[38]^[41] These steps are repeated if reinfestation occurs, as mites survive up to 48–72 hours off the body, potentially facilitating resurgence in crowded settings.^[63] Monitoring and evaluation are essential to assess outbreak resolution, involving post-treatment follow-up to track cure rates (typically aiming for >90% clinical resolution) and reinfection incidence through repeat screenings at 2–4 weeks.^[41]^[62] Public health reporting ensures coordination, with outbreaks declared over after two incubation periods (up to 8 weeks) without new cases.^[64] In low-resource settings, outbreak control faces significant hurdles, including drug supply chain disruptions and poor treatment compliance due to logistical barriers and limited health infrastructure.^[26] Integrating scabies MDA with broader hygiene and neglected tropical disease programs enhances feasibility and sustainability, addressing overlapping challenges like overcrowding and sanitation deficits.^[65]^[66]

Epidemiology

Global Burden and Prevalence

The Global Burden of Disease Study 2021 estimated that scabies had a global prevalence of 206.6 million cases and an incidence of 622.5 million new cases.^[67] In tropical and resource-poor regions, prevalence among children can reach 5–50%, while hyperendemic areas in the Pacific Islands report rates exceeding 30% in some communities.^[1]^[68] Recognized by the World Health Organization (WHO) as a neglected tropical disease (NTD) since 2017, scabies contributes significantly to morbidity through secondary bacterial infections, with pyoderma occurring in up to 70% of cases, particularly among children in endemic areas, and potentially leading to severe complications such as acute glomerulonephritis.^[1]^[26] The disease imposes a substantial global health burden, particularly in low- and middle-income countries, where it accounts for a large proportion of dermatological consultations.^[1] Prevalence remains stable at less than 1% in developed countries but has shown increases in crowded settings such as refugee camps and post-COVID institutional environments, with surges noted in high-income nations like those in Europe, including a tripling of incidence in England in 2024 compared to pre-pandemic averages.^[69]^[70] Geographically, the highest rates occur in resource-limited areas of sub-Saharan Africa and Southeast Asia, where environmental and socioeconomic factors drive endemic transmission.^[70] Seasonal peaks often align with dry and cool months, when increased indoor crowding facilitates mite spread.^[71] The intense pruritus of scabies disrupts sleep and daily activities, leading to reduced productivity and absenteeism from work or school.^[1] Crowding, a key transmission driver, exacerbates prevalence in vulnerable populations.^[26]

Risk Factors and At-Risk Populations

Scabies susceptibility is influenced by various demographic factors that facilitate close physical contact and transmission. Children under 15 years of age are at heightened risk due to their increased interpersonal interactions, such as playing and sharing bedding in schools or households, leading to higher prevalence rates in this group.^[26] Elderly individuals, particularly those in long-term care facilities, face elevated risk from reduced mobility, shared living spaces, and potential declines in personal hygiene practices.^[11] In certain institutional settings like prisons or dormitories, males may experience higher incidence owing to communal sleeping arrangements and close-contact activities, though overall sex-based differences vary by context.^[26] Environmental conditions significantly contribute to scabies transmission by promoting mite survival and human proximity. Overcrowded housing, such as in urban slums or family dwellings with multiple occupants, increases skin-to-skin contact opportunities, amplifying outbreak potential.^[1] Poor sanitation and homelessness exacerbate this vulnerability by limiting access to clean water and bedding, fostering conditions for fomite transmission.^[72] Tropical climates further favor scabies persistence, as warmer temperatures and humidity extend the Sarcoptes scabiei mite's viability outside the host, contributing to endemicity in regions like the Western Pacific and Central America.^[26] Health-related factors impair host defenses or enable secondary spread among contacts. Immunosuppression from conditions like HIV/AIDS, long-term corticosteroid use, or diabetes heightens susceptibility, often resulting in severe crusted scabies with heavy mite burdens.^[4] Malnutrition weakens skin integrity and immune response, particularly in resource-poor areas, increasing infestation risk.^[73] Close household or familial contacts of infested individuals represent a primary at-risk group due to prolonged direct contact, necessitating concurrent evaluation to curb transmission.^[4] Occupational exposures elevate risk for those in frequent-contact roles. Healthcare workers encounter scabies through patient interactions and fomites in clinical settings, with outbreaks reported in hospitals where unrecognized cases facilitate spread.^[74] Daycare staff and educators face similar hazards from children's close play, contributing to institutional transmission in childcare environments.^[64] Social determinants, including poverty and migration, underpin many scabies risks by entrenching environmental and health vulnerabilities. Impoverished communities often contend with inadequate housing and hygiene resources, perpetuating cycles of infestation.^[75] Migrants and refugees in camps experience particularly high prevalence—ranging from 20% to over 50% in some outbreaks—due to overcrowding and disrupted access to care, as highlighted in recent reviews of displaced populations.^[26]

History

Early Descriptions and Recognition

Descriptions of skin conditions resembling scabies, referred to as an "itch," appear in ancient Egyptian medical texts such as the Ebers Papyrus, dating to approximately 1500 BCE, where it was treated with applications of sulfur mixed with animal fats.^[76] In the 4th century BCE, the Greek philosopher Aristotle provided one of the earliest detailed accounts, describing scabies as "lice in the flesh" that caused contagious itchy eruptions and noting the presence of burrows from which the parasites could be extracted if pricked.^[77] The condition was first named "scabies," from the Latin scabere meaning "to scratch," by Roman encyclopedist Aulus Cornelius Celsus in the 1st century CE; he characterized it as a highly pruritic, contagious eruption and recommended topical sulfur compounds as an effective remedy.^[77] Biblical references to "zaraath" in ancient texts from the Middle East around the 5th century BCE likely encompassed scabies among other skin diseases, with sulfur-rich bathing in the Jordan River prescribed as a treatment.^[77] In medieval Europe, scabies was managed through herbal and mineral remedies, such as applications of sulfur, mercury, fern, chervil, and aromatic plants like ginger or basil, as described by figures like Hildegard of Bingen in the 12th century, though it was frequently linked to poor hygiene or supernatural causes.^[78]^[76] A pivotal advancement occurred in 1687 when Italian physicians Giovan Cosimo Bonomo and Giacinto Cestoni used early microscopy to observe and extract live scabies mites from burrows, demonstrating their role in causing the itch and egg-laying within the skin; their observations, emphasizing the disease's contagiousness, were detailed in a letter published in 1703.^[77]^[79] By the 19th century, scabies was formally classified as a type of acariasis, an infestation by mites of the genus Acarus (later identified as Sarcoptes scabiei), with Ferdinand von Hebra's work in the 1840s confirming the mite's causative role and the disease's direct transmissibility through contact, independent of humoral influences.^[80] Prior to these discoveries, pre-modern views often attributed scabies to imbalances in bodily humors like excess phlegm or bile, or even to moral sins, fostering stigma and reliance on ineffective oral purges rather than topical interventions.^[77]^[80]

Advances in Understanding and Treatment

In the early 20th century, the lifecycle of Sarcoptes scabiei was further confirmed through detailed observational studies, building on earlier microscopic identifications and establishing the mite's burrowing and egg-laying behaviors as key to its transmission.^[77] Sulfur ointments, used since antiquity, remained a cornerstone of treatment, while benzyl benzoate emerged as a standard topical scabicide by the 1930s due to its acaricidal properties and relative efficacy against the mite.^[81] These agents provided symptomatic relief but were limited by poor patient compliance and skin irritation. During the mid-20th century, particularly in the 1940s, dichlorodiphenyltrichloroethane (DDT) was trialed as a scabicide amid wartime efforts to control ectoparasites, showing initial promise in eradicating mites but ultimately abandoned due to its neurotoxicity and environmental persistence.^[82] Post-World War II, scabies gained recognition as a significant public health issue, with outbreaks in crowded settings prompting organized delousing programs and highlighting the need for scalable interventions in resource-limited areas.^[83] The 1970s and 1980s marked a pivotal shift with the development of permethrin, a synthetic pyrethroid introduced in 1979 as the first highly effective topical scabicide, offering superior mite kill rates and reduced toxicity compared to prior options.^[84] Concurrently, ivermectin, derived from avermectin isolated in 1975 from the bacterium Streptomyces avermitilis, was identified as a broad-spectrum antiparasitic agent, later adapted for scabies with oral dosing that targeted both mites and their lifecycle stages.^[84] In the late 20th century, the term "Norwegian" or crusted scabies dates to 1848, when it was described among leprosy patients in Norway. Its strong association with immunocompromised states, including HIV/AIDS, was further emphasized in clinical studies from the 1980s onward, distinguishing it from classical scabies by hyperinfestation with millions of mites.^[85]^[86] Community-based control programs were implemented in endemic regions during this period. The World Health Organization later integrated scabies into its neglected tropical diseases framework in 2017, spurring global control efforts.^[84] Entering the 21st century, scabies was officially classified as a neglected tropical disease by the WHO in 2017, underscoring its global burden and spurring coordinated elimination efforts.^[26] Reports of resistance to permethrin and ivermectin emerged in the 2000s, documented in clinical cases and in vitro studies showing reduced susceptibility in mite populations from treated areas.^[87] As of 2025, phase 2b trials of moxidectin, an oral macrocyclic lactone related to ivermectin, are evaluating its potential as a single-dose treatment for scabies, including in resistant cases, with preclinical data suggesting advantages in pharmacokinetics and efficacy.^[60]

Scabies in Animals

Animal Hosts and Variants

Sarcoptes scabiei is a highly adaptable mite with a broad host range, infesting over 100 species of mammals worldwide, including domestic, wild, and companion animals such as dogs, pigs, horses, foxes, and coyotes.^[88] Different variants of the mite are host-specific, with notable examples including S. scabiei var. canis in dogs, var. suis in pigs, and var. equi in horses.^[89]^[90]^[21] The morphology and lifecycle of S. scabiei in animals are generally similar to those in humans, featuring a burrowing habit where adult females excavate tunnels in the stratum corneum of the skin to deposit eggs. The complete lifecycle spans approximately 17-21 days and includes egg, larval, nymphal (protonymph and tritonymph), and adult stages, all occurring on the host. While the mites exhibit no unequivocal morphological differences across hosts, genetic adaptations contribute to host specificity, such as subtle variations in cuticle structure or leg morphology that enhance survival in particular species.^[91]^[6]^[92] In infested animals, clinical manifestations typically include intense pruritus leading to self-trauma, alopecia, hyperkeratosis, and crusting of the skin, often starting in sparsely haired areas like the ears, elbows, and abdomen. These signs characterize sarcoptic mange, a highly contagious condition within the same species, as seen in dogs where severe infestations can generalize across the body, causing secondary bacterial infections and debilitation. Similar presentations occur in pigs and horses, with pigs showing papular eruptions and rubbing against objects due to itching.^[89]^[90] Sarcoptic mange imposes significant veterinary and economic burdens, particularly in livestock production, where it leads to reduced weight gain, decreased fertility, and poorer feed conversion efficiency, resulting in substantial financial losses for pig farmers. In pigs, chronic infestations can cause condemnation at slaughter and increased treatment costs. Veterinary management often involves topical or systemic acaricides, such as selamectin applied topically or lime-sulfur dips administered weekly for 4-6 treatments to eliminate mites and prevent spread.^[93]^[94]^[95] Genetic analyses reveal distinct strains of S. scabiei adapted to specific hosts, with variations in mitochondrial and nuclear DNA markers indicating limited gene flow between animal and human populations. The human strain (var. hominis) rarely establishes sustained infestations in animals due to strong host preferences driven by these genetic differences, which influence mite survival and reproduction outside their primary host.^[96]^[97]

Zoonotic Transmission to Humans

Zoonotic transmission of scabies from animals to humans is infrequent and typically involves Sarcoptes scabiei variants adapted to animal hosts, such as var. canis from dogs, which cause transient, self-limiting skin infestations in people rather than sustained human scabies.^[98]^[36] These animal-derived mites induce pruritic papulovesicular rashes resembling human scabies but without burrows, resolving spontaneously within 1-4 weeks as the mites die off.^[98]^[95] Individuals at risk include pet owners with close contact to infested dogs, veterinarians, farmers handling livestock like cattle or sheep, and workers in environments such as kennels or zoos where outbreaks can occur among animals.^[98]^[91] Transmission happens through direct skin-to-skin contact with affected animals or indirectly via contaminated bedding or environments, with dogs being the most common source globally.^[98]^[95] Pathophysiologically, animal Sarcoptes mites burrow into human skin and elicit an immune response causing intense itching and inflammation, but they cannot reproduce or complete their lifecycle on human hosts due to host specificity, resulting in limited and temporary infestations.^[36]^[98] This contrasts with human-adapted mites, as animal variants lack the adaptations needed for long-term survival on people, though rare cases of persistence beyond a month have been documented.^[98]^[91] Diagnosis relies on a detailed clinical history of recent animal contact combined with characteristic symptoms like rapid-onset pruritus on the trunk, abdomen, or limbs; confirmatory microscopy of skin scrapings may reveal the variant mites, though they are often not found due to the transient nature.^[98]^[95] Dermoscopy can aid in visualization, but empirical assessment is common when exposure history is clear.^[98] Prevention centers on treating the infested animal source with appropriate acaricides, such as selamectin or lime sulfur dips, to eliminate the reservoir and halt transmission.^[91]^[95] In humans, symptomatic relief with topical antipruritics like calamine lotion or oral antihistamines suffices, as scabicides are unnecessary given the self-resolving course; avoiding contact with potentially infested animals is advised for at-risk groups.^[36]^[98]

Society and Culture

Public Health Impact and Stigma

Scabies is frequently stigmatized as a "dirty disease" due to misconceptions linking it to poor personal hygiene and poverty, despite evidence that transmission primarily occurs through close skin contact in overcrowded conditions rather than individual uncleanliness. This perception originates from cultural associations with socioeconomic disadvantage, leading to feelings of shame among affected individuals and significant delays in seeking treatment, as people fear judgment or social repercussions. In resource-limited settings, such views perpetuate a cycle where scabies is seen as a marker of moral or personal failing, further entrenching psychological barriers to care.^[42]^[99]^[100] The stigma surrounding scabies profoundly impacts affected individuals, causing social isolation, disrupted personal relationships, and absenteeism from school or work due to intense itching and fear of spreading the infestation. Patients often experience loneliness and withdrawal, with community members avoiding contact, which exacerbates mental health issues such as anxiety, depression, and reduced quality of life; for instance, studies indicate moderate to severe impairment in daily activities and self-perception among adults. In communities with high prevalence, like remote or impoverished areas, this fear of contagion disrupts social cohesion and amplifies the psychological toll.^[101]^[99]^[102] Cultural variations in stigma are evident across societies; in parts of Ghana, scabies is sometimes attributed to supernatural causes like witchcraft or curses, equating infection with moral failings and leading to rejection or shaming within families and communities. Among Indigenous groups, such as Aboriginal and Torres Strait Islander populations in Australia, high endemic rates are tied to broader health inequities, including overcrowding and limited access to treatment. Recent 2024 research highlights an elevated mental health burden, including low self-esteem and potential depression, underscoring the need for targeted psychosocial support. High prevalence in vulnerable populations further fuels these stigmatizing attitudes.^[100]^[103]^[101]^[104] Public health efforts, particularly through the World Health Organization (WHO), address stigma by integrating scabies into the 2021–2030 neglected tropical diseases roadmap, which promotes community education to dispel myths about hygiene and contagion, thereby improving case reporting and treatment uptake. These initiatives emphasize inclusive control strategies, such as mass drug administration, to normalize scabies as a treatable condition rather than a source of shame. Gender dynamics compound the issue, as women, who often serve as primary caregivers for children, bear disproportionate blame and emotional overburden during outbreaks, facing heightened stigma and isolation that affects their mental well-being.^[42]^[1]^[105]^[106] Scabies imposes substantial direct medical costs, particularly in low-income settings where treatment accessibility is limited. In Fiji, the average cost for a primary healthcare presentation related to scabies is approximately US$17.7 per case, while presentations for associated skin and soft tissue infections (SSTIs) average US$18.3.^[107] Hospitalizations for scabies-related complications, such as SSTIs, incur higher expenses, with an average cost of US$439 per admission in the same context.^[107] In many low- and middle-income countries (LMICs), these direct costs—encompassing medications, clinic visits, and topical treatments like permethrin—can represent a significant portion of monthly household income, often equivalent to one week's earnings for affected families.^[42]^[108] Indirect costs further amplify the economic burden through lost productivity and educational disruptions. Scabies-related itching and discomfort lead to missed workdays for caregivers and affected adults, as well as school absences for children, restricting family income and child development in impoverished communities.^[109]^[23] In resource-limited areas, these absences exacerbate financial strain, with families in poverty bearing the brunt due to the need for multiple treatment rounds and household decontamination.^[71] On a broader scale, scabies outbreaks strain healthcare systems and widen social inequalities, particularly in overcrowded urban slums and endemic regions. The condition contributes to an estimated annual healthcare expenditure of US$3.0 million in Fiji alone, or US$3.3 per capita, highlighting resource diversion from other priorities.^[107] Globally, scabies accounted for 5.3 million disability-adjusted life years (DALYs) lost in 2021, with the burden disproportionately higher in areas co-endemic with other neglected tropical diseases, underscoring its role in perpetuating cycles of poverty.^[67] Policy interventions, such as mass drug administration (MDA) with ivermectin, demonstrate cost-effectiveness by reducing case numbers and total treatment expenses compared to routine care, potentially yielding long-term savings through decreased transmission and complications.^[110]

Research Directions

Emerging Challenges and Resistance

One of the primary emerging challenges in scabies management is the development of resistance to permethrin, the first-line topical treatment, particularly in regions with high treatment prevalence. Reports indicate increasing treatment failures attributed to permethrin-resistant Sarcoptes scabiei mites in Australia, especially among Indigenous communities, and in parts of Europe such as Austria and Italy, where clinical non-response rates have reached up to two-thirds in some cohorts.^[59] This resistance is largely driven by knockdown resistance (kdr) mutations, such as the M918L polymorphism in the voltage-sensitive sodium channel (VSSC) gene, which reduces the neurotoxic effects of permethrin by altering its binding affinity to the mite's nerve cells.^[111] These genetic changes have been detected in mite populations exposed to repeated permethrin applications, underscoring the selective pressure from widespread use.^[59] Ivermectin, an oral alternative, faces limitations in severe cases like crusted scabies due to its suboptimal penetration into hyperkeratotic lesions, necessitating multiple doses and adjunctive keratolytic measures to achieve efficacy.^[49] Although true resistance remains rare, evidence of reduced susceptibility has emerged through alterations in glutamate-gated chloride channels, the primary target of ivermectin, which prolongs chloride influx and mite paralysis; mutations here can diminish this effect, as documented in isolated treatment-refractory cases.^[59]^[112] Diagnostic challenges further complicate scabies control, as traditional skin scrapings exhibit low sensitivity—often below 50%—in early infestations or low-burden cases, where mites are scarce and burrows subtle.^[113] Molecular methods, such as point-of-care PCR targeting mite DNA (e.g., cytochrome c oxidase subunit 1 gene), offer superior sensitivity approaching 95% on skin swabs or scrapings, enabling rapid detection but are hindered by high costs and limited accessibility in resource-poor settings.^[114]^[115] Climate change exacerbates transmission risks by potentially altering environmental conditions that favor mite survival off-host; warmer and more humid climates could extend viability from days to weeks in favorable microhabitats, facilitating prolonged fomite contamination and interpersonal spread in overcrowded areas.^[116]^[117] Secondary bacterial co-infections, particularly pyoderma caused by Staphylococcus aureus and Streptococcus pyogenes, represent another growing obstacle, with rising antibiotic resistance complicating management; methicillin-resistant S. aureus (MRSA) strains are increasingly isolated from scabies-associated lesions, leading to severe complications like post-streptococcal glomerulonephritis in endemic regions.^[118]^[119]

Future Therapeutic and Preventive Approaches

Ongoing research into new scabicides aims to address limitations of current treatments by developing agents with improved efficacy and pharmacokinetic profiles. Moxidectin, a macrocyclic lactone with a longer half-life than ivermectin, is under investigation as a single-dose oral therapy for scabies. Phase 2b clinical trials, such as NCT05875441, are evaluating single doses of 8 mg, 16 mg, or 32 mg moxidectin against standard ivermectin (200 mcg/kg) for potential higher cure rates at day 28 in adults, with recruitment completed in 2024. A dose-finding study (NCT03905265), completed and updated in 2025, is assessing safety and acaricidal activity, positioning moxidectin as a promising alternative for mass drug administration (MDA) in endemic areas. Experimental topical agents, including essential oils like tea tree oil, show in vitro acaricidal effects against Sarcoptes scabiei mites, killing them within 30-90 minutes at 5-10% concentrations, and are being explored as adjuvants to conventional therapies. Vaccine development represents a long-term strategy for scabies prevention, focusing on recombinant antigens to induce protective immunity across Sarcoptes strains. Preclinical studies have identified paramyosin as a candidate vaccine antigen, with recombinant forms (rPmy) eliciting immune responses in animal models that reduce mite burdens and fertility. Other recombinant proteins, such as those derived from Ssag1 and Ssag2 antigens, have been tested in rabbits, producing IgG antibodies but requiring further optimization for cross-strain protection. These efforts aim to target conserved mite proteins for broad-spectrum immunity, potentially integrating with neglected tropical disease (NTD) control programs. Advancements in diagnostics are enhancing early detection in resource-limited settings. AI-assisted dermoscopy applications, like ScabAI, use deep learning on mobile devices to analyze skin images for scabies lesions, achieving high sensitivity in screening clinical and dermoscopic photos. Multiplex PCR assays, including portable Biomeme qPCR platforms, enable simultaneous detection of scabies DNA alongside other skin NTD pathogens in field samples, improving diagnostic accuracy from skin scrapings. Preventive approaches emphasize integrated and innovative strategies to curb transmission. Conceptual applications of genetic engineering, such as CRISPR-based editing to induce sterility in Sarcoptes mites, build on the mite's sequenced genome and existing RNAi tools for gene silencing, offering a future vector control method. Integrating scabies control into onchocerciasis MDA programs has shown feasibility, with combined ivermectin dosing reducing scabies prevalence by up to 79% in co-endemic regions. Research priorities for 2025 highlight the need for enhanced resistance surveillance and MDA optimization to achieve elimination in high-burden hotspots, including monitoring rising incidence trends in regions like the UK (from 99 to 1341 episodes per 100,000 patient-years between 2014 and 2023). Recent reviews underscore monitoring ivermectin and permethrin resistance through genomic surveillance, alongside refining MDA protocols for sustained coverage and impetigo co-reduction.^[120]

References

[1]
Scabies - World Health Organization (WHO)
May 31, 2023 · Scabies is a parasitic infestation caused by tiny mites that burrow into the skin and lay eggs, causing intense itching and a rash.
[2]
About Scabies - CDC
Sep 9, 2024 · Scabies is an infestation of the skin by a human itch mite. Scabies causes intense itching and a pimple-like skin rash.
[3]
Scabies - Symptoms and causes - Mayo Clinic
Jul 28, 2022 · Scabies is an itchy skin rash caused by a tiny burrowing mite called Sarcoptes scabiei. Intense itching occurs in the area where the mite burrows.
[4]
Scabies - StatPearls - NCBI Bookshelf - NIH
Scabies is a contagious skin condition caused by the mite Sarcoptes scabiei which burrows into the skin and causes severe itching.Bookshelf · Scabies · Treatment / Management
[5]
Symptoms of Scabies | Parasites - CDC
Jan 12, 2024 · The most common signs and symptoms of scabies are intense itching (pruritus), especially at night, and a pimple-like (papular) itchy rash.Missing: definition | Show results with:definition
[6]
DPDx - Scabies - CDC
Severe itching, especially at night and frequently over much of the body, including areas where mites are undetectable, is the most-common symptom of scabies. A ...Missing: definition | Show results with:definition
[7]
Scabies: Diagnosis and Treatment with Images - DermNet
Scabies is a very itchy rash caused by a parasitic mite that burrows in the skin surface. Scabies is usually spread by skin-to-skin contact.Scabies Images · Crusted scabies · Scabies pathology · Institutional scabies
[8]
Scabies | Red Book Online | American Academy of Pediatrics
Sites of predilection in older children and adults are the interdigital folds, flexor aspects of wrists, extensor surfaces of elbows, anterior axillary folds, ...
[9]
Scabies: Epidemiology, Diagnosis, and Treatment - PMC - NIH
Scabies is a skin infestation whose incidence is apparently rising. This review is based on pertinent articles retrieved by a selective search of PubMed on ...
[10]
Scabies: A clinical update - RACGP
Scabies lesions are often secondarily infected with Streptococcus pyogenes (Group A Streptococcus [GAS]) and/or Staphylococcus aureus because of breaches in the ...
[11]
Clinical Overview of Crusted scabies | Parasites - CDC
Dec 18, 2023 · Scabies is an infestation of the skin by a human itch mite. View All · For Everyone · About · Signs and Symptoms · How It Spreads · Preventing ...
[12]
Crusted Scabies, a Neglected Tropical Disease: Case Series ... - NIH
Jun 16, 2022 · Crusted scabies is a rare form of scabies that presents with more severe symptoms than those of classic scabies.
[13]
Public Health Strategies for Crusted Scabies Outbreaks in ... - CDC
Dec 18, 2023 · ... characteristic signs or symptoms of scabies are absent (e.g. no itching). ... characteristic symptoms of scabies such as rash and itching ...Missing: typical | Show results with:typical
[14]
Scabies outbreaks in ten care homes for elderly people - NIH
Scabies outbreaks in residential and nursing care homes for elderly people are common, subject to diagnostic delay, and hard to control.
[15]
A review of Sarcoptes scabiei: past, present and future - PMC - NIH
Jun 20, 2017 · In the case of human scabies, live mites in bedding, furniture, toys, and clothing can be a source of infection. Sarcoptes scabiei var. hominis ...Missing: lifecycle | Show results with:lifecycle
[16]
Sarcoptes Scabiei - an overview | ScienceDirect Topics
The life cycle of S. scabiei consists of five stages: egg, larva, protonymph, tritonymph, and adult (Fig. 1) (Fain, 1968; Arlian and Vyszenski-Moher, 1988). ...<|control11|><|separator|>
[17]
https://doi.org/10.1016/S0190-9622(84)70151-4
[18]
Sarcoptes Scabiei - an overview | ScienceDirect Topics
Clinical manifestations. The characteristic pruritis and rash of scabies primarily reflect a delayed type-IV hypersensitivity reaction to the mite, its saliva, ...
[19]
https://pubmed.ncbi.nlm.nih.gov/16282315/
[20]
How Scabies Spreads - CDC
Feb 23, 2024 · Scabies is spread to close personal contacts with whom you have prolonged, direct skin-to-skin contact or share bedding or clothing.
[21]
Scabies: Background, Pathophysiology, Etiology
Aug 1, 2025 · Mite life cycle · Eggs incubate and hatch in 3-4 days (90% of the hatched mites die) · Larvae (with three pairs of legs) migrate to the skin ...
[22]
A review of Sarcoptes scabiei: past, present and future
Jun 20, 2017 · Host-parasite interactions (immune modulation) As scabies mites burrow into the skin, they release substances that induce inflammatory and ...
[23]
Scabies: Immunopathogenesis and pathological changes - PMC - NIH
Mar 4, 2024 · Scabies is an itchy skin disease caused by the burrowing mite Sarcoptes scabiei. During their lifespan, the female mites invade the stratum corneum and create ...Missing: debris | Show results with:debris
[24]
Detection of scabies: A systematic review of diagnostic methods - PMC
This study systematically reviewed the accuracy and precision of history, physical examination and tests for diagnosing scabies.
[25]
Clinical practice guidelines for the diagnosis and treatment of scabies
Visualizing burrows, a specific clinical sign of scabies facilitates the diagnosis. If dermoscopy is unavailable, burrows can be revealed with an ink test ...
[26]
Scabies: Epidemiology, clinical features, and diagnosis - UpToDate
Jul 25, 2025 · The diagnosis of scabies is confirmed through the detection of scabies mites, eggs, or feces with microscopic examination.
[27]
Scabies: Advances in Noninvasive Diagnosis - PMC - PubMed Central
Jun 16, 2016 · The differential diagnosis of scabies includes a variety of pruriginous skin diseases, such as atopic dermatitis, contact dermatitis, papular ...
[28]
Laboratory-based diagnosis of scabies: a review of the current status
Mar 25, 2021 · Using ink to highlight burrows provides a partial answer but does not distinguish old from new lesions.
[29]
Sight the Mite: A Meta-Analysis on the Diagnosis of Scabies - NIH
Jan 30, 2023 · In this paper, we investigated several tools most commonly used to verify scabies infection, including skin scraping, tape test, PCR, dermoscopy ...
[30]
Comparison of Dermoscopy, Skin Scraping, and the Adhesive Tape ...
Apr 11, 2011 · The sensitivity of dermoscopy increased parallel to the severity of scabies (light scabies, 0.80; moderate scabies, 0.85; and severe scabies ...
[31]
Accuracy of standard dermoscopy for diagnosing scabies
Sensitivities were 91% (95% confidence interval: 86-96) for DS and 90% (95% confidence interval: 85-96) for microscopic examination of skin scrapings (P = .005 ...
[32]
Diagnosis of scabies with dermoscopy - CMAJ
Jun 3, 2008 · Dermoscopy for scabies is 91% sensitive (95% confidence interval [CI] 80%–92%) and 86% specific (95% CI 80%–92%) (magnification × 10).1 For ...
[33]
Preventing Scabies | Parasites - CDC
Dec 18, 2023 · The scabies mites that infest animals cannot survive or reproduce on humans. However, they can get under your skin and cause temporary itching ...Missing: definition | Show results with:definition
[34]
[PDF] Scabies: important information - NHS Borders
Good hygiene helps, such as daily baths, frequent handwashing and changing clothes regularly. Pets cannot pass on the mites. It is a human infection that ...Missing: prevention | Show results with:prevention
[35]
Public Health Strategies for Scabies Outbreaks in Institutional Settings
Dec 18, 2023 · Scabies is an infestation of the skin by a human itch mite. View All · For Everyone · About · Signs and Symptoms · How It Spreads · Preventing ...Overview · Prevention · Control & Treatment
[36]
Ectoparasitic Infections - STI Treatment Guidelines - CDC
Jul 22, 2021 · Scabies is a skin infestation caused by the mite Sarcoptes scabiei, which causes pruritus. Sensitization to S. scabiei occurs before pruritus ...Pediculosis Pubis · Scabies · PregnancyMissing: definition | Show results with:definition<|separator|>
[37]
https://www.nhsborders.scot.nhs.uk/media/197859/scabies-June-2014.pdf
[38]
Scabies control guidelines - Health.vic
Jul 10, 2024 · Gowns and gloves should be single use. Gowns and gloves should be changed between each patient. Hands should be washed thoroughly after ...
[39]
Scabies: current knowledge and future directions - Frontiers
Jul 22, 2024 · Bacterial infection may co-exist with scabies when the burrowing of mites and associated scratching breaches the skin barrier together with the ...
[40]
Scabies as a part of the World Health Organization roadmap ... - NIH
Aug 16, 2021 · Adding scabies to the global health agenda as an NTD would promote disease awareness and global discussions and collaboration, and encourage ...
[41]
Clinical Care of Scabies | Parasites - CDC
Dec 18, 2023 · Scabies is an infestation of the skin by a human itch mite. View All · For Everyone · About · Signs and Symptoms · How It Spreads · Preventing ...
[42]
Permethrin treatment in scabies infestation: importance of the correct ...
With the 5% permethrin preparation for treating scabies, a response rate of over 90% is anticipated after a single application, and success can often be ...
[43]
[Translated article] RF – Resistance to Permethrin in Scabies ...
This treatment is repeated after 7 to 14 days. Cure rates of up to 98% have been described for this regimen,1 but recent months have seen an increase in ...
[44]
Scabies - Diagnosis and treatment - Mayo Clinic
Jul 28, 2022 · Learn more about this contagious condition that causes intense itching, usually in areas where the skin folds, such as around joints.Missing: facts | Show results with:facts
[45]
Scabies Treatment & Management - Medscape Reference
Aug 1, 2025 · Scabies treatment includes administration of a scabicidal agent (eg, permethrin, ivermectin, or lindane), as well as an appropriate antimicrobial agent.<|separator|>
[46]
Treatment of Scabies | Parasites - CDC
Jan 12, 2024 · Your healthcare professional can prescribe a cream or lotion to apply to skin that kills scabies mites, called scabicides.
[47]
The efficacy of permethrin 5% vs. oral ivermectin for the ... - PubMed
A single dose of ivermectin provided a cure rate of 62.4%, which increased to 92.8% with 2 doses at a 2-week interval. Treatment with two applications of ...
[48]
Ivermectin Use in Scabies - AAFP
Sep 15, 2003 · Oral ivermectin is an effective and cost-comparable alternative to topical agents in the treatment of scabies infection.
[49]
[PDF] Scabies Protocol - BOP
Identification of the mites confirms the diagnosis, while the eggs or scybala (fecal pellets) provide indirect confirmation. → Microscopic verification is not ...
[50]
Ivermectin: MedlinePlus Drug Information
Apr 10, 2020 · if you are taking ivermectin for strongyloidiasis and have had loiasis (Loa loa infection with a type of worm that causes skin and eye problems ...
[51]
Ivermectin (Stromectol) Use During Pregnancy - Drugs.com
Jan 3, 2025 · The manufacturer considers ivermectin contraindicated during pregnancy. Two cases of the use of ivermectin during pregnancy have been reported.Missing: scabies loa
[52]
Ivermectin (oral route) - Side effects & dosage - Mayo Clinic
Feb 1, 2025 · It works by interfering with the nerve and muscle functions of worms, by paralyzing and killing them. This medicine is available only with your ...
[53]
Wonder drug for worms: A review of three decades of ivermectin use ...
The safety of ivermectin in pregnancy and lactation has not been established in humans. It is a pregnancy category C drug.
[54]
Clinical practice guidelines for the diagnosis and treatment of scabies
Jun 23, 2024 · A combination of 5% permethrin or benzyl benzoate with oral ivermectin treatment is suggested for crusted scabies. The recommended treatment ...
[55]
Scabies Prevention and Control Guidelines
Nov 15, 2023 · Scabies outbreaks should be treated aggressively to prevent spread in institutional settings. In general, a person who has any skin-to-skin ...
[56]
Mass Drug Administration for the Control of Scabies - PubMed Central
Our findings demonstrate that mass drug administration is highly effective in reducing the prevalence of scabies and impetigo.
[57]
Guidelines for Control of Scabies in Long Term Care Facilities
The recommended treatment for scabies is 5% permethrin cream. Application of this cream to the skin of an infested resident should be supervised by the staff of ...
[58]
[PDF] MANAGEMENT OF SCABIES IN LONG- TERM CARE FACILITIES ...
This document has been developed to provide a rational approach to the prevention and control of scabies within a healthcare facility, prison, school or other ...
[59]
Scabies as a part of the World Health Organization roadmap for ...
Aug 16, 2021 · Scabies is considered a public health challenge for underprivileged communities in many low-income and middle-income countries, and also in some ...
[60]
A framework for scabies control | PLOS Neglected Tropical Diseases
Sep 2, 2021 · This framework will allow countries to set control targets for scabies as part of national NTD strategic plans and develop control strategies using MDA.
[61]
Estimation of scabies prevalence using simplified criteria and ...
Nov 10, 2021 · The prevalence of scabies (either 'Clinical Scabies' or 'Suspected Scabies') was 33.8% in Timor-Leste, 15% in Solomon Islands, and 14% in Fiji ( ...
[62]
Scabies on the Rise Worldwide, Even in High-Income Countries
May 16, 2025 · Despite being preventable and treatable, scabies affects more than 130 million people worldwide at any given time, contributing to over 1.5 ...
[63]
Prevalence and determinants of scabies: A global systematic review ...
Pooled global prevalence was 11.9% (95% CI: 9.60%–14.7%). Scabies prevalence ranged widely from 0.4% to 71% (Figure 2), with marked variation by WHO region.
[64]
Scabies: An updated review from epidemiology to current ...
The pathophysiology of scabies results from complex interactions between the host immune system and the mite-derived antigens released during infestation [1,3].
[65]
https://tropmedhealth.biomedcentral.com/articles/10.1186/s41182-021-00348-6
[66]
Problems in Diagnosing Scabies, a Global Disease in Human and ...
Scabies is caused by the ectoparasitic mite Sarcoptes scabiei burrowing into the host epidermis. Clinical symptoms include intensely itchy lesions that often ...
[67]
Risk factors associated with scabies infestation among primary ...
May 25, 2021 · ... age, or sex and the main contributing factors are poor hygiene, poverty, and overcrowded living conditions [8]. Scabies affects all social ...Missing: immunosuppression | Show results with:immunosuppression
[68]
[PDF] Scabies Outbreak Among Healthcare Workers and ... - JournalAgent
Scabies can cause significant morbidity in both healthcare workers and patients. Factors such as inadequate knowledge of scabies epidemiology, atypical ...Missing: daycare | Show results with:daycare
[69]
Risk factors for scabies in hospital: a systematic review
Mar 26, 2024 · The identified risk factors were low economic status and unhygienic behavioral practices. Being a patient in a long-term care facility or institution was an ...Missing: daycare | Show results with:daycare
[70]
Skin disease in antiquity - ScienceDirect.com
Dermatological conditions and treatment in antiquity can be assessed by studying ancient skin, artefacts illustrating medical disorders and literature.
[71]
Scabies: a historical perspective - PMC - NIH
In 25 AD, the Roman author Aulus Cornelius Celsus was credited with first giving the name “scabies” to the disease and using a sulfur compound as a remedy.
[72]
Causes and Cures of Skin Diseases in the Work of Hildegard of ...
Mentioned are remedies based on certain plants, especially burdock, oats, wormwood (Artemisia species) or acanthus, which are very well established in Europe, ...
[73]
Giovan Cosimo Bonomo (1663-1696): discoverer of the etiology of ...
From 1685 to 1687, and probably at the Spa of the city of Livorno, Italy, they studied the morphology and physiology of Sarcoptes scabies, explained the ...
[74]
Von Hebra – Legend in dermatology
Apr 17, 2020 · In 1841, Hebra described how to differentiate between psoriasis and leprosy. In 1844, he concluded that scabies is caused by a mite and there ...Missing: 1840s acariasis
[75]
[PDF] MITES OF PUBLIC HEALTH IMPORTANCE AND THEIR CONTROL
Control measures may be divided into two main ... Commercially, 1% lindane is available in a vanishing cream which has been widely used to control both scabies ...
[76]
DDT - A Brief History and Status | US EPA
Sep 11, 2025 · DDT was the first of the modern synthetic insecticides, developed in the 1940s. It helped control diseases such as typhus and malaria.Missing: scabies sulfur benzyl benzoate century,
[77]
History | AMEDD Center of History & Heritage
Soon after the 20th General Hospital arrived in thetheater and its personnel ... Uncomplicated scabies could be treated effectively withsulfur ointment or ...
[78]
The Management of Scabies in the 21st Century: Past, Advances ...
This review gives an overview of the current limitations in the management of scabies, an update on recent advances, and outlines prospects for potential ...
[79]
Control Strategies for Scabies - MDPI
Sep 5, 2018 · Crusted scabies (formerly known as Norwegian scabies) is a rare form of the disease characterized by hyperinfestation with thousands to millions ...
[80]
Scabies in the age of increasing drug resistance - PMC
Nov 30, 2017 · Resistance to scabicides is increasing throughout the years. This constitutes a big problem because of the bothersome symptoms of an infestation ...
[81]
Efficacy and Safety Study of Moxidectin in Adults With Scabies
This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28.
[82]
Universal conventional and real-time PCR diagnosis tools for ... - NIH
Nov 14, 2015 · The mite Sarcoptes scabiei has a known host-range of over 100 mammal species including humans. One of the prime objectives of the Sarcoptes ...
[83]
Sarcoptic mange (scabies)
Other primary hosts include foxes, coyotes and wolves. Transient hosts include cats, horses and other hoofed animals. The mites live in the outer layer of the ...Missing: range | Show results with:range
[84]
Mange in Pigs - Integumentary System - Merck Veterinary Manual
Mange in pigs is mainly caused by Sarcoptes scabieisuis, with rare cases of Demodex phylloides. Sarcoptic mange is primary, and Demodectic is rare.Sarcoptic Mange In Pigs · Demodectic Mange In Pigs · Mange In Dogs And Cats
[85]
Mange in Dogs and Cats - Integumentary System
The entire life cycle (17–21 days) is spent on the host dog. Female mites burrow into the stratum corneum to lay their eggs. Sarcoptic mange is readily ...
[86]
High-throughput metagenome analysis of the Sarcoptes scabiei ...
Aug 13, 2019 · Although some physiological differences may determine host preferences, no unequivocal morphological differences exist between the two S.
[87]
Sarcoptic mange infestation in pigs: an overview - PMC - NIH
Feb 11, 2014 · The economic losses due to sarcoptic mange infestation are also caused by decreased fertility of sows and lower feed conversion ratio ( ...
[88]
Sarcoptic Mange in Dogs - PetMD
Mar 8, 2022 · The life cycle is complete within 3 weeks. Scabies usually affects dogs suffering from starvation and neglect and those with compromised immune ...
[89]
Sarcoptic Mange in Dogs | VCA Animal Hospitals
Some of the dips that are used to treat Sarcoptes include amitraz and lime-sulfur dip. Given the advent of newer and more effective treatments, dips are no ...
[90]
Genetically distinct dog-derived and human-derived Sarcoptes ...
Because of the apparent genetic separation between human scabies and dog scabies, control programs for human scabies in endemic areas do not require resources ...Missing: strain differences
[91]
Sarcoptes scabiei mites in humans are distributed into three ...
Crusted scabies is usually associated with host factors such as older age and immunosuppressed conditions, but it is not known whether parasite factors may ...
[92]
Zoonotic Episodes of Scabies: A Global Overview - PMC
Feb 6, 2022 · In this episode, people became infested through direct contact with different species of domestic animals (pigs, goats, dogs, horses, oxen) that ...<|control11|><|separator|>
[93]
Perceptions, attitudes and practices towards scabies in communities ...
Jul 7, 2025 · There was a general perception that people affected by scabies suffer from stigma. Feelings of rejection, embarrassment and shame were ...Table 1. Demographic... · Perceptions: Disease... · DiscussionMissing: humoral imbalance<|control11|><|separator|>
[94]
Beliefs, attitudes and practices towards scabies in central Ghana
Feb 22, 2023 · Scabies commonly affects poor populations in low-middle-income countries. The WHO has advocated for country-driven and country-owned control strategies.<|separator|>
[95]
Quality of life among adults with scabies: A community-based cross ...
This pervasive stigma can have a toll on the mental health of scabies patients warranting psychosocial interventions alongside clinical care. 'Daily activity' ...
[96]
Scabies Affects Quality of Life in Correlation with Depression ... - NIH
Scabies often causes severe itching and patients suffered from social stigma, sleep disruption, difficulties in concentration and productivity [2,5]. It was ...
[97]
Scabies in Aboriginal & Torres Strait Islander populations
Sep 30, 2021 · Scabies can present differently in remote Aboriginal and Torres Strait Islander communities where rashes on the head and neck are more likely, ...
[98]
The Impact of Neglected Tropical Diseases (NTDs) on Women's ...
Feb 23, 2021 · Findings revealed that NTDs disproportionately affect women and girls due to their assigned gender roles and responsibilities; women take on ...
[99]
Awareness, Attitudes, Perceptions and Practices of Scabies ...
Findings from the FGDs showed that the community had a stigma towards caregivers of children infested with scabies, due to the perception that they were ...
[100]
Costs of primary healthcare presentations and hospital admissions ...
Oct 10, 2024 · The estimated annual healthcare costs of scabies and related SSTIs in Fiji was US$3.0 million, with cost per capita of $3.3. Scabies and related ...
[101]
Estimating the global burden of scabies: what else do we need?
21 The global prevalence of scabies was estimated to be 100 625 000 people worldwide in 2010, but a subsequent GBD analysis based on more recent data for 2013 ...Summary · Other gaps in the estimation of... · Integration of skin Neglected...
[102]
Paediatrics: how to manage scabies - PMC - PubMed Central - NIH
Scabies causes a large burden on families living in poverty due to the cost of treatment, absence from school and missed workdays, thus restricting the ...Missing: loss | Show results with:loss
[103]
A systematic analysis from the Global Burden of Disease Study 2021
In 2021, scabies caused 5.3 million DALYs, 206.6 million prevalence, and 622.5 million incidence, primarily affecting children and young people.
[104]
Cost-effectiveness of mass drug administration for control of scabies ...
Sep 17, 2024 · Results of our analysis suggest that single-dose ivermectin MDA is cost-effective in scabies control and can be initiated at a scabies prevalence >10%.
[105]
Escalating Threat of Drug-Resistant Human Scabies - NIH
Sep 18, 2024 · The traditional pillars of scabies treatment involve the use of topical permethrin 5% and oral ivermectin [1,3]. This strategy is still ...
[106]
Detection of a knockdown mutation in the voltage-sensitive sodium ...
The kdr-associated M918L mutation in the VSSC gene has now emerged in S. scabiei var. hominis mites. Hence, loss of sensitivity to permethrin due to kdr-type ...
[107]
First Documentation of In Vivo and In Vitro Ivermectin Resistance in ...
... glutamate-gated chloride channels may account for our cases of ivermectin resistance. The presence of ivermectin-sensitive mites in the recurrences that our ...
[108]
2020 International Alliance for the Control of Scabies Consensus ...
Microscopy of skin scrapings can confirm the diagnosis, but it is insensitive, invasive and often impractical. Diagnosis usually relies on clinical assessment, ...
[109]
Molecular diagnosis of scabies using a novel probe-based ...
Feb 24, 2021 · We have developed two PCR-based diagnostic assays targeting repetitive DNA elements. These were identified using new data on the S. scabiei genome.
[110]
Development of Conventional and Real-Time Quantitative PCR ...
Jun 18, 2015 · Conclusion. Our study showed that cox1 PCR of skin swab samples has a better sensitivity for the diagnosis of scabies than microscopic ...
[111]
Climate Factors Affecting Scabies: 14-Year Study in Taiwan
Dec 1, 2016 · Many studies, in fact, have reported high incidences of scabies infestations during the cool weather of the fall and winter seasons [1, 25, 26].Missing: peaks dry
[112]
A Scabies Mite Serpin Interferes with Complement-Mediated ... - NIH
Jun 19, 2014 · Reports of scabies patients co-infected with methicillin resistant S. aureus (MRSA) pose a major concern for serious down-stream complications.Missing: antibiotic | Show results with:antibiotic
[113]
Positive Methicillin-Resistant Staphylococcus Aureus
Dec 22, 2023 · Among the secondary pyoderma, infected eczema was the most common cause, accounting for 55% (65/118) of the cases, followed by infected scabies, ...